The medicine that
transforms
lives
Medical news, research and health. Analysis of clinical advances, new treatments and medical technology. No noise, just what matters.
Medicine
Featured
WATCHMAN FLX: Could This Device Replace Blood Thinners for AFib Patients?
IT Support for Your Medical Practice: Discover TotalPro.es
TotalPro.es provides specialized IT solutions for medical practices. Find out how they can solve any technology problem in your clinic or surgery.
WATCHMAN FLX: A Game-Changer for AFib Patients Who Can't Tolerate Blood Thinners?
The CHAMPION-AF trial shows WATCHMAN FLX left atrial appendage closure is safe and effective as first-line therapy for select atrial fibrillation patients.
WATCHMAN FLX: A New First-Line Option for AFib Without Blood Thinners?
The CHAMPION-AF trial shows WATCHMAN FLX is safe and effective as first-line therapy for certain AFib patients, challenging anticoagulant dominance.
Orforglipron: The First GLP-1 Pill You Can Take Anytime, Anywhere
The FDA approves Lilly's orforglipron, the first GLP-1 pill requiring no fasting or special water. What does this mean for diabetes and obesity patients?
More articles
Medical Burnout in Latin America: A Silent Crisis in Med Schools
Burnout and depression are devastating medical students across Latin America. Experts demand humanizing medical education before the consequences become irreversible.
Burnout in Latin American Medical Schools: A Crisis That Can't Wait
Burnout and depression are devastating Latin American medical students. Experts demand humanizing medical education before the crisis deepens further.
Orforglipron: The First GLP-1 Pill With No Food or Water Restrictions
The FDA approves Lilly's orforglipron (Foundayo), the first oral GLP-1 receptor agonist that can be taken anytime without food or water restrictions.
Orforglipron: The First GLP-1 Pill You Can Take Anytime, Anywhere
The FDA approves Lilly's orforglipron, the first GLP-1 pill requiring no fasting or specific water intake. What does this mean for obesity treatment?
Orforglipron: The First GLP-1 Pill You Can Take Without Fasting
The FDA approves Lilly's orforglipron (Foundayo), the first oral GLP-1 receptor agonist requiring no fasting or special water intake. What it means for patients.
Adopting a Pet: The Surprising Health Benefits You Should Know
Find out how adopting a pet improves your physical and mental health. Discover cachorros.info, the new free platform to adopt pets in Spain.
How the Human Body Changes in Space: What Science Reveals
Space science reveals deep changes in bones, muscles, vision and DNA. Discover what happens to the human body beyond Earth's atmosphere.
Italy Recognises Obesity as a Chronic Disease: A European Milestone
Italy becomes a European benchmark by legally recognising obesity as a chronic disease. We analyse what changes for patients and healthcare systems across the continent.
Augmented and virtual reality in medicine: from surgical simulator to AR operating room
VR reduces resident operative time by 30%. AR in the operating room overlays CT on the operative field in real time. State of the art in 2026.
Alzheimer in 2026: blood biomarkers and the first disease-modifying treatments
Lecanemab and donanemab modify Alzheimer's course. Plasma p-tau217 biomarkers make early diagnosis accessible. A complete state-of-the-art review.
Chronic migraine: anti-CGRP antibodies and gepants change the paradigm
Anti-CGRP monoclonal antibodies and gepants have revolutionized prevention and acute treatment of chronic migraine. A full review of 2026 options.
Acute myocardial infarction: updated management protocol
From prehospital ECG to drug-eluting stent: a review of the current STEMI protocol, antiplatelet therapy, and post-infarction management.
Type 2 diabetes in 2026: the era of GLP-1 receptor agonists
Semaglutide, tirzepatide, and retatrutide are rewriting type 2 diabetes treatment in 2026. New guidelines, cardiovascular and renal benefits.
Arterial hypertension: updated 2026 treatment guidelines
The 2026 hypertension guidelines update control targets, recommend the polypill, and validate renal denervation. A comprehensive review.